Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TRIple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure ConTrol With the TRICH Score

NCT07458880 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT07458880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07458880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TRIple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure ConTrol With the TRICH Score
Lead sponsor
The University of Hong Kong
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2026
Completion date
June 30, 2030
Enrollment
140 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage